Table 4.

Functional outcome following sarcoma resection.

Paper Patient population Comparison Outcome measure Impact on functional outcome
Davis et al. [58] Lower extremity STS Function of patients with limb salvage
  • MSTS 87

  • MSTS 93

  • TESS

  • SF-36

Large tumor size:
  • Lower extremity MSTS 1987, MSTS 1993, TESS

Motor nerve resection (femoral, obturator, sciatic, peroneal, and posterior tibial nerves):
  • Lower MSTS 1987, MSTS 1993, TESS

Postoperative complications”
  • Lower MSTS 1987

High-grade tumors:
  • Lower MSTS 1993 and TESS

Bone resection:
  • Lower MSTS 1993

Davis et al. [32] Extremity STS Pre- vs. Postoperative radiotherapy
  • MSTS

  • TESS

  • SF-36

Postoperative radiotherapy:
  • Improved MSTS, TESS, and SF-36 at 6 weeks postoperative only

SF-36 compared to normative data:
  • Lower for both treatment arms across all time points

Wound complications:
  • Lower MSTS at 6 weeks, 3, 6, 12, and 24 months

  • Increased disability compared to baseline TESS

Large tumor size (>10 cm):
  • Lower MSTS scores at 6, 12, and 24 months

Motor nerve resection:
  • Lower MSTS scores

Previous unplanned excision:
  • Lower TESS score at 3, 6, 12, and 24 months

Davis et al. [31] Extremity STS Late morbidity:
  • Pre- (50 Gy) vs. Postoperative (66 Gy) radiotherapy

  • MSTS

  • TESS

Subcutaneous fibrosis:
  • Decreased MSTS and TESS

Joint stiffness:
  • Decreased MSTS and TESS

Extremity lymphedema:
  • Decreased MSTS and TESS

Pre- vs. Postoperative radiotherapy:
  • No difference in MSTS or TESS

  • Trend toward greater fibrosis with postoperative radiotherapy

Payne et al. [63] Upper extremity STS with flap coverage Pedicled vs. Free flap for wound coverage
  • MSTS 87

  • MSTS 93

  • TESS

Pedicled vs. free flaps:
  • Decreased MSTS 87 from pre- to postoperative in patients with either pedicled or free flap

  • Decreased MSTS 93 for free flaps

  • No difference in TESS between groups

  • Patients rated their function better compared to the actual rated impairment

Davis et al. [66] Lower extremity limb salvage sarcoma patients Relationship of symptoms to function during 1st year postoperative
  • Stiffness

  • Fatigue

  • Pain

  • Weakness

  • Limited range of motion

  • TESS

Stiffness:
  • Plateaus at 3 months

  • Remains constant over the year

Fatigue:
  • Plateaus at 3 months

  • Remains constant over the year

Pain:
  • Constant for 3 months then declines over study

Weakness:
  • Constant for 3 months then declines over study

  • Limited Range of Motion:

  • Constant decline over study

TESS:
  • Presence of pain, stiffness, weakness, and limited range of motion were predictors of worse outcome

Gerrand et al. [59] Lower Extremity Limb Salvage Sarcoma patients Sarcoma location and functional outcome:
  • Groin/Femoral triangle

  • Buttock

  • Anterior thigh

  • Medial thigh

  • Posterior thigh

  • Popliteal fossa

  • Posterior calf

  • Anterolateral leg

  • Foot and ankle

  • MSTS 93

  • TESS

Deep vs. superficial:
  • Superficial tumors have improved MSTS and TESS scores

Superficial tumors:
  • No decrease in MSTS or TESS from to pre- to postoperative

Deep Tumors:
  • No difference in MSTS or TESS based on tumor location

Groin/Femoral triangle tumors:
  • Increased pain based on the MSTS compared to other anatomic areas

  • Decreased ability to sit, put on socks, getting in and out of bath, bending to pick up items

  • More likely to have a limp or gait handicap

Buttock/Posterior thigh:
  • Decreased ability to sit

Ghert et al. [46] Lower extremity limb salvage sarcoma patients Vascular reconstruction and functional outcome:
  • Femoral

  • Iliofemoral

  • Popliteal

  • Tibial/Peroneal

  • TESS

Vascular reconstruction:
  • More likely to need a muscle flap, have a wound complication, sustain a deep vein thrombosis (DVT), suffer from edema of the limb, and require an amputation

  • No difference in the postoperative TESS

Jones et al. [45] Lower extremity limb salvage sarcoma patients Nerve resection and functional outcome:
  • Femoral

  • Sciatic

Comparison of femoral nerve resection and location:
  • Gender-matched large anterior thigh

  • All large anterior thigh

  • MSTS 87

  • MSTS 93

  • TESS

Femoral nerve resection:
  • No difference in MSTS 87, MSTS 93, or TESS between patients with sciatic nerve resection, gender-matched large anterior thigh tumors, or all patients with large anterior thigh tumors

  • Long-term risk of falling which could lead to fracture

Pradhan et al. [67] Patients with STS of the adductor compartment Outcome of treatment of adductor compartment STS
  • TESS

Impact on TESS:
  • Wound complications and high-grade tumors had lower TESS

  • Timing of radiotherapy (pre- vs. postoperative) had no effect on TESS

  • Need for a muscle flap; had no effect on TESS

Riad et al. [62] Patients with radiation induced STS Outcome of treatment in patients with a radiation-induced STS compared to patients with a sporadic STS
  • MSTS 87

  • TESS

Radiation induced vs. Sporadic STS:
  • No difference in the MSTS 87 or TESS

MSTS 87 = Musculoskeletal Tumor Society Functional Rating System 1987, a measure of impairment; MSTS 93 = Musculoskeletal Tumor Society Functional Rating System 1993, a measure of impairment; TESS = Toronto Extremity Sarcoma Salvage Score, a measure of functional disability; SF-36 = 36-Item Short Form Health Survey, a quality of life measure.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.